Compare Main Street Capital Corporation (MAIN) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Main Street Capital Corporation vs 22nd Century Group Inc — how do they compare? Main Street Capital Corporation trades at $53.74 (market cap $5.09B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Main Street Capital Corporation is far larger — about 8187.6× 22nd Century Group Inc's market cap, and Main Street Capital Corporation pays a 5.84% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Main Street Capital Corporation for 89 Days and 22nd Century Group Inc for 32 Days on average.
| MAIN | XXII | |
|---|---|---|
Market Cap | $5.09B | $621.67K |
Volume | 524,060 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $64.60 | $483.00 |
52-Week Low | $49.63 | $0.80 |
Typical Hold Time | 89 Days | 32 Days |
Enterprise Value | $7.54B | -$3.69M |
Dividend Yield | 5.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Main Street Capital (MAIN) trades at $53.74, down 0.81% on the day, with a bearish technical signal from moving averages. The stock shows strong profitability with an 80.77% net income margin and a P/E of 10.94, indicating potential undervaluation. Recent earnings have been mixed, with a beat in Q2 2026 but a miss in Q1 2026. The company maintains a consistent monthly dividend, recently paying $0.27 per share, supporting income-focused investors.
The outlook is cautiously optimistic given MAIN's robust fundamentals and analyst consensus price target of $58.33, suggesting upside. However, risks include softening revenue projections for 2026 and bearish technical trends. Investors should weigh the high dividend yield against potential earnings volatility and market sentiment shifts.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
